
Aulos Bioscience Unveils Phase 2 Data for IL-2 Antibody AU-007 at EORTC-NCI-AACR Symposium
AU-007 Showcases Unique IL-2 Class Profile with Promising Efficacy Data Aulos Bioscience, a pioneering company in the field of immuno-oncology, recently presented significant data supporting the dose selection for its…












